SRF's stock experienced a 12% drop over the past five days, primarily due to concerns about inflated valuations and increased market volatility. Factors contributing to this decline include uncertainties surrounding US tariff policies, climbing input costs, and the influence of fluctuating crude prices on profit margins.

SRF Ltd has opened a new BOPP film manufacturing plant in Indore, India, at an investment of INR 277 Crore. The company also plans to expand the facility in phase 2, with an estimated cost of INR 6 Cr, expected to commence in September 2026, as approved by the board.

Today, Bharti Airtel and Cipla will announce their Q4 earnings. Notable changes include CLSA revising Dixon's target price down to Rs 10,400, while HSBC has initiated a buy recommendation for SRF at Rs 3,390. The moves by Dr Reddy's and Dixon in response to results remain to be seen.

HSBC has recommended buying shares in SRF with a projected price of ₹3,390, highlighting potential growth in specialty chemicals and performance films, contributing to half of the company's revenue from global markets.

HSBC shows positivity towards SRF and Nomura is optimistic about Sagility. Notably, Jefferies has recommended purchasing shares in Grasim, as reported by CNBC TV18.

China's intensified regulations are inadvertently aiding chemical companies in India, notably Aarti, SRF, and Navin. This is due to reduced competition in the market, leading to improved pricing and profit margins.

The Nifty Midcap index has reached a new high of 14,223.9, marking an impressive 13% increase over the past month. This outpaces the 5% growth seen in the Nifty 50 during the same period. Key contributors to this rise include SRF, Yes Bank, and HPCL, among others, with gains ranging from 2% to 8%.

Citi recommends selling shares in SRF due to increased production of R32 and potential price changes, which could significantly impact earnings. The new target price is set at ₹2675.

SRF Ltd has postponed the launch of its ₹490 crore BOPP film plant in Indore due to shifting market conditions. The company is now reconsidering the investment timeline, with a focus on strategic diversification and selective capacity growth instead.

The ongoing turmoil in the Middle East is projected to pose a risk for SRF's short-term sales, potentially affecting their revenue stream.

SRF discussed volume growth during their Q2 conference call, indicating positive progress in their operations.

SRF Ltd reports a 7% revenue growth in Q4 FY26, reaching INR 4,615 crores with EBIT expanding by 12%. Profit After Tax (PAT) increased by 11% to INR 582 crores. Notably, the board postponed a BOPP plant investment of INR 490 crores but approved an ambitious INR 2,300 crore refrigerants project.

SRF is experiencing difficulties in maintaining sales in West Asia, a significant market for the company, according to recent conference call updates.

SRF's shares experienced a 9% increase due to optimistic forecasts for a potential 15-20% expansion in their chemical sector. This promising growth outlook suggests a positive trajectory for the company's financial performance.

SRF's shares climbed 5%, driven by a 11% increase in Q4 profits, and the announcement of a significant Rs 2,300 crore investment plan in Odisha.

SRF Ltd significantly increases capital expenditure for its Odisha plants from ₹1,100 crore to ₹2,285 crore, aiming to complete two plants producing 20,000 MTPA of HFOs and 30,000 MTPA of AHF by February 2028.

SRF's impressive financial results have sparked investor interest and optimism. The company's recent conference call added fuel to the growing market excitement.

Jefferies has downgraded SRF to 'Underperform', setting a new price target at ₹2,640. The positive points include strong performances in refgas and a 25% expansion of HFC capacity, but these may not be enough to outweigh the overall outlook.

HDFC Securities has adjusted its portfolio, reducing exposure to automotive stocks while increasing investments in financials and chemicals. Head Varun Lohchab expresses concern about auto sector margins and recommends SRF, Neogen Chemicals, and Aether as potential investments instead.

SRF Limited announces a standalone revenue of ₹12,420.5 crore and profit of ₹1,724.6 crore for the fiscal year 2026, but no final dividend was declared by the Board. The audited results and related documents are now available on their website.

SRF has expressed concerns about global market unpredictability, pointing to potential threats to demand forecasts. During a recent conference call, they highlighted these issues in their operational outlook.

SRF Limited has approved an investment of INR 88 crores to expand hydrofluorocarbon (HFC) production capacity beyond 65,000 MTPA. The project is expected to be completed within eight months, with financing coming from both debt and internal resources.

SRF anticipates a 15-20% increase in revenue for the upcoming year, optimistic about their performance amidst global uncertainties as shared by the company's recent management update following a conference call.

Morgan Stanley maintains a cautious stance towards SRF, setting a target price of INR 2,209, suggesting potential below the current market value. Investors may want to consider this before making decisions regarding their holdings in SRF.

SRF faces a setback in Q4 as sales in West Asia decline, likely due to ongoing regional conflicts. The company may need to adjust its strategies to recover losses in this market.

L&T's Q4 revenue remained stable but earnings fell short of expectations, while SRF Ltd experienced a 10.6% increase in net profit to ₹582 crore. Remarkably, Poonawalla Fincorp recorded a significant 309% rise in Q4 net profit to ₹255 crore, and UCO Bank saw a substantial reduction in GST liabilities following an appellate ruling.

Hero Motors struggles under increased margin pressure, potentially affecting short-term profits. On the other hand, SRF aims for a significant 15-20% growth in their specialty chemical division, while KPIT Technologies reports slightly disappointing results.

SRF reports an impressive 10% year-on-year increase in their Q4 revenue, reaching ₹46.2 billion. This growth demonstrates a positive financial performance for the company.

Anticipation builds as both Coforge and SRF prepare to announce their Q4 results, with the market eagerly waiting for crucial insights that could impact future performance.

SRF Ltd's board will convene on May 5, 2026, to discuss and potentially decide on the financial results and dividend distribution. The trading window for SRF shares is now closed from April 1 until May 7 due to insider trading regulations.

SRF Limited successfully overturned a ₹36.9 crore CGST penalty imposed by the Gwalior office, following a decision by CESTAT Delhi in their favor. This ruling marks a significant win for SRF Ltd.

Ganesh Dongre from Anand Rathi suggests investing in SRF, Bank of India, and Sai Life Sciences amid ongoing US-Iran talks. The Nifty index experienced a significant rebound of 5.5%, closing at 24,050, due to strong buying interest. The Bank Nifty is approaching the resistance level at 57,000.

Infosys teams up with Harness for AI-enhanced software delivery, while GAIL seals an LNG deal with Alpha Gas. SRF confronts a tax demand of ₹327.4 crores, and Muthoot Finance sets the interim dividend record date for FY26 on April 13, 2026.

SRF is facing a significant tax demand of INR 327.4 crore due to a technical error, with an additional INR 101.8 crore for interest. The company has submitted rectification requests and appeals, hoping to reverse the decision. Currently, this issue is not expected to impact their financials.

SRF Ltd. conducted a significant share transaction worth about INR 22.49 crores, with each share priced at INR 2,398.8 in the NSE.

The Nifty Chemicals index experienced a 3.4% drop due to the government's decision to eliminate import duties on crucial petrochemicals, potentially causing increased competition for companies like Swan Energy (-5.6%) and SRF (-5.5%). Analysts predict these firms may face margin pressures as a result.

Page Industries experienced a 4% growth in share price today, while SRF, PG Electroplast, Amber, and Biocon saw declines.

SRF Ltd has been issued a tax demand notice worth approximately ₹103.1 crores, which includes penalties and interests. The company has announced plans to challenge the order in court. Despite this, they anticipate no significant impact beyond the already disclosed amount.